Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
A study published in the journal Stem Cells Reports reveals that a cellular reprogramming methodology allows the creation of neural networks that reproduce unique characteristics of human ...
In part, this is due to the difficulty in recreating adequate animal or cellular models. By reprogramming skin cells into neurons, Johan Jakobsson and his research group have been able to study ...
Human-induced pluripotent stem cells (hiPSCs) can differentiate into various tissues, an invaluable characteristic for personalized regenerative medicine, basic and translational research, and drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results